Anebulo Pharmaceuticals Inc (ANEB) — Financial Flexibility Index
Anebulo Pharmaceuticals Inc (ANEB) has a Financial Flexibility Index of -0.88x as of December 2025. Free cash flow of $-1.31 Million (operating CF $-1.31 Million minus capex $0.00) represents -1% of total liabilities ($1.49 Million). Also explore ANEB shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Anebulo Pharmaceuticals Inc Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Anebulo Pharmaceuticals Inc across 6 annual periods. See Anebulo Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Anebulo Pharmaceuticals Inc (2020–2025)
Year-by-year free cash flow to debt coverage for Anebulo Pharmaceuticals Inc. For the full company profile including market capitalisation, see ANEB stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -13.02x | $-6.35 Million | $-6.35 Million | $487.69K | ▲ +58.1% |
| 2024 | -31.05x | $-8.09 Million | $-8.09 Million | $260.58K | ▼ -242.7% |
| 2023 | -9.06x | $-9.68 Million | $-9.68 Million | $1.07 Million | ▲ +14.6% |
| 2022 | -10.61x | $-5.44 Million | $-5.44 Million | $512.53K | ▲ +47.4% |
| 2021 | -20.16x | $-4.87 Million | $-4.87 Million | $241.63K | ▼ -2893.3% |
| 2020 | -0.67x | $-150.77K | $-150.77K | $223.87K | — |